Allspring Global Investments
VRCA icon

Allspring Global Investments’s Verrica Pharmaceuticals VRCA Stock Holding History

Allspring Global Investments’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-628
Closed -$24.4K – 2765
2023
Q3 		$24.4K Buy
+628
New +$31.9K ﹤0.01% 2465
2022
Q2 		– Sell
-511
Closed -$41K – 2953
2022
Q1 		$41K Sell
511
-59
-10% -$4.86K ﹤0.01% 2870
2021
Q4 		$52K Buy
+570
New +$64.6K ﹤0.01% 2844

Other funds holding VRCA

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Allspring Global Investments's VRCA Position: Q4 2023 in Review

Allspring Global Investments sold out of Verrica Pharmaceuticals (VRCA) in Q4 2023, closing a stake of 628 shares — an estimated $24.4K sold.

Allspring Global Investments first reported a position in VRCA in Q4 2021 and held it in 3 quarters. The position peaked at $52K in Q4 2021. 64 funds tracked by Wall St. Rank hold VRCA as of Q4 2023.

  • Allspring Global Investments reported no remaining Verrica Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 628 Verrica Pharmaceuticals shares in Q4 2023, an estimated $24.4K.
  • Allspring Global Investments first reported a position in Verrica Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's Verrica Pharmaceuticals position peaked at $52K in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.